HomeComparePHRRF vs QSR

PHRRF vs QSR: Dividend Comparison 2026

PHRRF yields 4155.41% · QSR yields 3.40%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PHRRF wins by $10365691035278.95M in total portfolio value
10 years
PHRRF
PHRRF
● Live price
4155.41%
Share price
$0.05
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$10365691035278.97M
Annual income
$9,897,164,253,693,497,000.00
Full PHRRF calculator →
QSR
QSR
● Live price
3.40%
Share price
$73.90
Annual div
$2.51
5Y div CAGR
-0.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.7K
Annual income
$386.99
Full QSR calculator →

Portfolio growth — PHRRF vs QSR

📍 PHRRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPHRRFQSR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PHRRF + QSR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PHRRF pays
QSR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PHRRF
Annual income on $10K today (after 15% tax)
$353,210.06/yr
After 10yr DRIP, annual income (after tax)
$8,412,589,615,639,472,000.00/yr
QSR
Annual income on $10K today (after 15% tax)
$288.70/yr
After 10yr DRIP, annual income (after tax)
$328.94/yr
At 15% tax rate, PHRRF beats the other by $8,412,589,615,639,472,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PHRRF + QSR for your $10,000?

PHRRF: 50%QSR: 50%
100% QSR50/50100% PHRRF
Portfolio after 10yr
$5182845517639.50M
Annual income
$4,948,582,126,846,749,000.00/yr
Blended yield
95.48%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on QSR right now

PHRRF
No analyst data
Altman Z
-14.2
Piotroski
1/9
QSR
Analyst Ratings
27
Buy
15
Hold
2
Sell
Consensus: Buy
Price Target
$81.57
+10.4% upside vs current
Range: $71.00 — $90.00
Altman Z
1.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PHRRF buys
0
QSR buys
0
No recent congressional trades found for PHRRF or QSR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPHRRFQSR
Forward yield4155.41%3.40%
Annual dividend / share$2.00$2.51
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%-0.8%
Portfolio after 10y$10365691035278.97M$24.7K
Annual income after 10y$9,897,164,253,693,497,000.00$386.99
Total dividends collected$10333779416010.36M$3.7K
Payment frequencyquarterlyquarterly
SectorStockStock

Year-by-year: PHRRF vs QSR ($10,000, DRIP)

YearPHRRF PortfolioPHRRF Income/yrQSR PortfolioQSR Income/yrGap
1← crossover$426,241$415,541.24$11,037$336.93+$415.2KPHRRF
2$17,009,425$16,553,347.24$12,154$344.76+$17.00MPHRRF
3$635,556,863$617,356,778.09$13,357$351.99+$635.54MPHRRF
4$22,238,480,006$21,558,434,161.98$14,651$358.62+$22238.47MPHRRF
5$728,787,067,208$704,991,893,601.52$16,041$364.68+$728787.05MPHRRF
6$22,371,952,866,480$21,592,150,704,567.71$17,534$370.18+$22371952.85MPHRRF
7$643,400,978,312,961$619,462,988,745,827.60$19,136$375.14+$643400978.29MPHRRF
8$17,338,253,847,239,070$16,649,814,800,444,200.00$20,856$379.58+$17338253847.22MPHRRF
9$437,875,496,808,855,800$419,323,565,192,309,950.00$22,699$383.52+$437875496808.83MPHRRF
10$10,365,691,035,278,973,000$9,897,164,253,693,497,000.00$24,675$386.99+$10365691035278.95MPHRRF

PHRRF vs QSR: Complete Analysis 2026

PHRRFStock

PharmaTher Holdings Ltd., a clinical-stage psychedelics biotech company, focuses on the research, development, and commercialization of novel uses, formulations, and delivery methods of psychedelics to treat mental illness, neurological, and pain disorders. The company's product in pipeline includes Ketamine intravenous injection, which is in Phase II and III clinical trials for Parkinson's disease, anesthesia and sedation, and amyotrophic lateral sclerosis indications. Its pipeline also comprises Ketamine Patch that is in Phase I and II clinical trials for treating depression, mental health, complex regional pain syndrome, and pain disorders; and Ketamine Pump, which is in Phase II clinical trial to treat metal health, pain disorders, and surgery/procedure. In addition, the company engages in the development of PHARMAPATCH, a microneedle patch to deliver psychedelics. It has collaboration agreements with LTS Lohmann Therapie-Systeme AG for developing Ketamin microneedle patch; Alcami Corporation to develop Ketamin injectables/infusions; BioRAE, Inc. for the development of Ketamin pumps; Revive Therapeutics Ltd. to develop psilocybin microneedle patch; Gesval S.A. for the development of patented continuous-flow process technology for the preparation of ketamine and ketamine analogs; and PharmaTher's to create a proprietary wearable ketamine delivery solution for mental health, neurological and pain disorders. The company was incorporated in 2019 and is headquartered in Toronto, Canada.

Full PHRRF Calculator →

QSRStock

Restaurant Brands International Inc. operates as quick service restaurant company in Canada and internationally. It operates through four segments: Tim Hortons (TH), Burger King (BK), Popeyes Louisiana Kitchen (PLK), and Firehouse Subs (FHS). The company owns and franchises TH chain of donut/coffee/tea restaurants that offer blend coffee, tea, and espresso-based hot and cold specialty drinks; and fresh baked goods, including donuts, Timbits, bagels, muffins, cookies and pastries, grilled paninis, classic sandwiches, wraps, soups, and others. It is also involved in owning and franchising BK, a fast food hamburger restaurant chain, which offers flame-grilled hamburgers, chicken and other specialty sandwiches, french fries, soft drinks, and other food items; and PLK quick service restaurants that provide Louisiana style fried chicken, chicken tenders, fried shrimp and other seafood, red beans and rice, and other regional items. In addition, the company owns and franchises FHS restaurants quick service restaurants that offer subs, soft drinks, and local specialties. As of February 15, 2022, the company had approximately 29,000 restaurants in 100 countries under the Tim Hortons, Burger King, Popeyes, And Firehouse Subs brands. Restaurant Brands International Inc. was founded in 1954 and is headquartered in Toronto, Canada.

Full QSR Calculator →
📬

Get this PHRRF vs QSR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PHRRF vs SCHDPHRRF vs JEPIPHRRF vs OPHRRF vs KOPHRRF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.